30
Participants
Start Date
August 23, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2027
ONC-841
ONC-841 (anti-SIGLEC10) is a humanized antibody that binds to human sialic acid-binding Ig-like lectin 10 and has a human immunoglobulin G4 (IgG4) Fc domain.
NOT_YET_RECRUITING
UF Health Cancer Center, University of Florida, Gainesville
NOT_YET_RECRUITING
AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
RECRUITING
Norton Cancer Center, Louisville
NOT_YET_RECRUITING
Rogel Cancer Center, University of Michigan, Ann Arbor
RECRUITING
Tranquil Clinical Research, Houston
NOT_YET_RECRUITING
Huntsman Cancer Institute, University of Utah, Salt Lake City
RECRUITING
University of California at Davis Cancer Center, Sacramento
NOT_YET_RECRUITING
MD Anderson Cancer Center, Houston
OncoC4, Inc.
INDUSTRY